Celldex (CLDX) announced the appointment of Teri Lawver as Senior Vice President, Chief Commercial Officer. Lawver is a global healthcare executive with 30 years of leadership experience. Lawver succeeds Richard Wright, who will retire from Celldex.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLDX:
- Celldex’s Promising Phase II Trial Results Justify Buy Rating
- Celldex’s Promising Phase 2 Trial Results and Strong Financial Position Support Buy Rating
- Celldex’s Barzolvolimab Shows Promising Phase 2 Results, Justifying Buy Rating
- Celldex announces additional data on barzolvolimab
- Celldex presents results from Barzolvolimab Phase 2 Study in ColdU, SD